EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Sequential Barrier Navigation by Yeast β-Glucan-Engineered Liposomal Nanovaccines Potentiates Oral Melanoma Immunotherapy

Dongyang Wu iD, Chenyang Jiang iD, Hui Li iD, Kairui Zhu, Wenyan Liu, Yang Guo, Weili Liu, Rui Yan, Zuoyuan Liang, Xiaoke Liu iD, Zhixin Zhao, Hongfang Sun und 1 weitere

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s631311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Dongyang Wu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Shandong Medical and Pharmaceutical University Hospital, Shandong Medical and Pharmaceutical University, Binzhou, Shandong, 2…. Hauptthemen laut MEDLINE: Nanovaccines, Liposomes, beta-Glucans, Melanoma, Experimental. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanovaccinesLiposomesbeta-GlucansMelanoma, ExperimentalCancer VaccinesAnimalsMiceHumansAdministration, OralImmunotherapyOvalbuminFemaleBoronic AcidsSaccharomyces cerevisiaeMice, Inbred C57BLCaco-2 CellsCell Line, TumorRAW 264.7 Cells

Stichwörter der Autor:innen

antigen-presenting cellsmelanoma immunotherapyoral nanovaccinephenylboronic acidsequential barrier navigationyeast β-glucan

Substanzen

NanovaccinesLiposomesbeta-GlucansOvalbuminbenzeneboronic acidBoronic AcidsCancer Vaccines

Autor:innen und Institutionen

  • Department of Pharmacy, Shandong Medical and Pharmaceutical University Hospital, Shandong Medical and Pharmaceutical University, Binzhou, Shandong, 256603, People's Republic of China.
  • Department of Biochemistry and Molecular Biology, Shandong Medical and Pharmaceutical University, Yantai, Shandong, 264003, People's Republic of China.

ORCID-Profile: Dongyang Wu, Chenyang Jiang, Hui Li, Xiaoke Liu, Yan Liang

Zitieren

APA

Wu, D., Jiang, C., Li, H., Zhu, K., Liu, W., Guo, Y., Liu, W., Yan, R., Liang, Z., Liu, X., Zhao, Z., Sun, H., & Liang, Y. (2026). Sequential Barrier Navigation by Yeast β-Glucan-Engineered Liposomal Nanovaccines Potentiates Oral Melanoma Immunotherapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s631311

Vancouver

Wu D, Jiang C, Li H, Zhu K, Liu W, Guo Y, et al. Sequential Barrier Navigation by Yeast β-Glucan-Engineered Liposomal Nanovaccines Potentiates Oral Melanoma Immunotherapy. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s631311

BibTeX
@article{Wu2026,
  author = {Wu, Dongyang and Jiang, Chenyang and Li, Hui and Zhu, Kairui and Liu, Wenyan and Guo, Yang and Liu, Weili and Yan, Rui and Liang, Zuoyuan and Liu, Xiaoke and Zhao, Zhixin and Sun, Hongfang and Liang, Yan},
  title = {Sequential Barrier Navigation by Yeast β-Glucan-Engineered Liposomal Nanovaccines Potentiates Oral Melanoma Immunotherapy},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s631311}
}
Kostenlos starten →